COHANCE LIFESCIENCES
Back to Cashflow Statement
|
COHANCE LIFESCIENCES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹288 Cr | ₹385 Cr | ₹457 Cr | ₹330 Cr | ₹383 Cr |
What is the latest Cash Flow from Operating Activities ratio of COHANCE LIFESCIENCES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹288 Cr |
| Mar2024 | ₹385 Cr |
| Mar2023 | ₹457 Cr |
| Mar2022 | ₹330 Cr |
| Mar2021 | ₹383 Cr |
How is Cash Flow from Operating Activities of COHANCE LIFESCIENCES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹288 Cr | -25.11 | |
| Mar2024 | ₹385 Cr | -15.84 | |
| Mar2023 | ₹457 Cr | 38.54 | |
| Mar2022 | ₹330 Cr | -13.74 | |
| Mar2021 | ₹383 Cr | - | |
Compare Cash Flow from Operating Activities of peers of COHANCE LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| COHANCE LIFESCIENCES | ₹17,041.0 Cr | -1.3% | 7.5% | -48.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,952.0 Cr | 1.8% | -1.6% | 16.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹230,427.0 Cr | -1.2% | 17.3% | 38.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,141.0 Cr | -2.3% | -2% | 33.6% | Stock Analytics | |
| CIPLA | ₹114,715.0 Cr | 0.2% | 1.7% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,409.9 Cr | 1.2% | 3.6% | -7% | Stock Analytics | |
COHANCE LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| COHANCE LIFESCIENCES | -1.3% |
7.5% |
-48.5% |
| SENSEX | 0.5% |
2.1% |
-4.5% |
You may also like the below Video Courses